POPULARITY
69 episodes with nyu langone
118 episodes with nyu langone
12 episodes with nyu langone
16 episodes with nyu langone
11 episodes with nyu langone
7 episodes with nyu langone
5 episodes with nyu langone
5 episodes with nyu langone
4 episodes with nyu langone
3 episodes with nyu langone
8 episodes with nyu langone
9 episodes with nyu langone
2 episodes with nyu langone
4 episodes with nyu langone
2 episodes with nyu langone
3 episodes with nyu langone
3 episodes with nyu langone
2 episodes with nyu langone
Can high-precision radiation change how we treat metastatic prostate cancer? In this episode, I'm joined by Ronald C. Chen, MD, MPH—radiation oncologist, national guideline author (AUA/ASCO), and clinical-trial leader with 170+ publications—to unpack stereotactic body radiation therapy (SBRT) for disease that has spread to lymph nodes, bones, and beyond. We get practical about who benefits, where SBRT shines, and how to balance treatment intensity with quality of life.SBRT offers highly focused, short-course radiation that can control limited (“oligo-”) metastatic prostate cancer and delay systemic therapy for many men. Dr. Chen explains when to treat individual nodes/bone lesions versus comprehensive nodal fields, how anatomy determines dose/fraction choices (often 3–5 treatments), and why modern SBRT sometimes reduces the need for concurrent hormone therapy. We cover salvage options after prior radiation (brachytherapy seeds, HIFU, cryo, repeat SBRT, or salvage prostatectomy), the role and limits of PSMA PET, fracture risk and bone health (DEXA), and the evolving data—including the large NRG-GU013 trial—for higher-risk disease. Throughout, we emphasize shared decision-making, realistic expectations, and considering clinical trials when data are evolving.00:00 – Can SBRT change metastatic prostate cancer care? Meet Dr. Ron Chen.01:00 – Disclaimer: Views are Dr. Geo's and guests'—independent of NYU Langone.07:00 – Recurrence scenarios: prostate-only, nodal, or bone/other; why catching early matters.12:00 – Five salvage options after prostate radiation: seeds (brachytherapy), HIFU, cryo, SBRT (focal or whole-gland), or salvage prostatectomy.19:00 – Nodal relapse: treat all pelvic nodes + ADT ± abiraterone vs. SBRT to a few nodes only—how patient priorities drive the plan.26:30 – Oligometastasis: SBRT alone can control disease for many men ~2+ years on average, delaying hormones.30:00 – Fractions: why 3–5 treatments is typical and how adjacent bowel/organ anatomy sets the pace.31:00 – SBRT in 2 fractions for select primary cases looks promising; high-risk SBRT under study (NRG-GU013).37:00 – Bone mets: SBRT preferred; understanding fracture risk (tumor size, dose, shrinkage).40:00 – DEXA before ADT; spine SBRT can spare the spinal cord with modern planning.48:00 – Clavicle/hilar nodes: SBRT near lung/heart/esophagus—safe with careful dose constraints.56:00 – Why clinical trials matter for “how long on hormones?” and other open questions.57:00 – Soft-tissue mets (liver/brain): SBRT can help, often alongside systemic therapy.59:00 – Parting advice: early detection, close follow-up, and hopeful trajectory of care.___________________________________
Is androgen deprivation therapy (ADT) always necessary when prostate cancer patients undergo radiation? And if so, for how long—six months, a year, two years? In this insightful conversation, Dr. Geo sits down with Dr. Nima Aghdam, radiation oncologist at NY CyberKnife and NYU Langone, to explore the evolving role of ADT in prostate cancer treatment.Dr. Aghdam shares his expertise on advanced radiation techniques like SBRT, personalized approaches to ADT duration, and the importance of lifestyle interventions. Together, they highlight how individualized care can improve survival, minimize side effects, and help men thrive beyond diagnosis.If you or a loved one are facing decisions about radiation and hormone therapy for prostate cancer, this episode offers clarity, evidence-based guidance, and hope.Radiation vs. Surgery: Both are highly effective; choice often comes down to quality-of-life goals and patient preference.Lymph Node Positive Disease: Options include focal SBRT or comprehensive external beam therapy; treatment decisions must balance efficacy and quality of life.Lifestyle's Role: Exercise and nutrition create a “hostile microenvironment” for cancer, improving both survival and side-effect management.Radiation Innovations: From rectal spacers to fewer treatment sessions (trials reducing SBRT from five to two fractions), techniques continue to evolve.ADT Considerations:Historically prescribed for up to 24–36 months with radiation.New genomic and AI-based classifiers may allow some men to stop ADT earlier (6–12 months).Balancing survival benefits with quality of life is critical.PSA Anxiety: PSA fluctuations don't always equate to recurrence or mortality. Context and long-term monitoring matter more than isolated numbers.Finding the Right Oncologist: Beyond equipment and technology, trust and honest communication with your doctor are essential.Timestamps00:00 – Introduction: Is ADT always necessary during radiation?05:00 – Radiation vs. surgery for localized and advanced prostate cancer.10:00 – Salvage options: what happens if radiation or surgery fails?13:00 – Treating prostate cancer with lymph node involvement.17:00 – Communicating metastasis risk and long-term outcomes to patients.18:30 – Lifestyle interventions as part of prostate cancer care.21:00 – Rectal spacers and preparation for SBRT.23:30 – Advances in SBRT: reducing from five fractions to two.25:30 – Understanding fractions, dosage, and radiation delivery.32:00 – Personalizing ADT: who benefits, and for how long?36:00 – Clinical trials on ADT duration (6, 12, 18, 24+ months).39:00 – Radiation's long-lasting effects and how ADT fits in.42:00 – PSA recurrence vs. actual risk of mortality45:00 – Patient anxiety and the psychological impact of PSA testing.47:00 – Exercise and lifestyle: evidence for improved survival.49:00 – Supplements, PSA manipulation, and misinformation.51:00 – How to choose a reputable radiation oncologist.56:00 – Evolving evidence: are radiation-related risks lower today?58:00 – Parting words: seeing prostate cancer as a chance for transformation.___________________________________
Dr. Patricia Tan serves as Medical Director for Rusk Pediatrics Rehabilitation. Her Certification is from the American Board of Physical Medicine & Rehabilitation. She has been selected as a Fellow by the following organizations: American Academy of Physical Medicine and Rehabilitation; American Academy of Pediatrics; American Academy of Cerebral Palsy and Developmental Medicine; and the Association of Academic Physiatrists. Her medical degree is from the University of Santo Tomas in Manila, Philippines. Dr. Megan Conklin is Associate Director of Rusk Pediatric Therapy Services at NYU Langone. She works collaboratively with an interdisciplinary team across the spectrum of pediatric diagnoses from birth through the transition into adulthood. She has a Doctor of Physical Therapy degree, 20 years of clinical experience at NYU; and is certified as a clinical specialist in pediatric physical therapy by the American Board of Physical Therapy Specialties of the American Physical Therapy Association. Part 1 The discussion included the following topics: kinds of health problems and conditions treated; age range of patients; clinical guidelines and evidence-based treatment protocols used; holistic approaches to treatment; collaboration with families of patients; and composition of the health care team
Eighty percent of us will develop fibroids by age 50–making them an epidemic nobody talks about. Tennis legend Venus Williams, 45, has recently spoken up about the debilitating pain, fatigue, and heavy bleeding she suffered with due to fibroids for literally decades. This week we talk with the doctor who finally helped her find relief, Dr. Taraneh Shirazian, Founder and Director of the Center for Fibroid Care at NYU Langone Health. We shine some much needed light on what fibroids are, common symptoms, how fibroids intersect with perimenopause, menopause, and hormone therapy, and what we can do about them. Dr. Taraneh Shirazian is the Founder and Director of the Center for Fibroid Care at NYU Langone Grossman School of Medicine, a state-of-the-art wellness center that takes a holistic, multidisciplinary approach to treating fibroids, abnormal uterine bleeding, and pelvic pain while prioritizing patients' life goals, including family planning. A minimally invasive gynecologic surgeon and Associate Professor at NYU Langone, she also directs Global Women's Health in OBGYN and at NYU's College of Global Public Health, where she has taught for seven years. She is the Founder and President of Saving Mothers, a nonprofit dedicated to reducing preventable maternal deaths worldwide. Recognized as a leader in women's health and an advocate for patient education and empowerment, Dr. Shirazian specializes in fibroids, endometriosis, ovarian cysts, pelvic pain, and abnormal bleeding, and is frequently featured as a women's health expert on major media outlets including CBS, CNN, The Today Show, Good Morning America, Newsweek, and The Wall Street Journal. You can follow her on Instagram @drshirazianResources:Venus Williams Opens Up About Her 30-Year Fibroids Journey, Self MagazineVenus Williams Shares Her Journey with Uterine Fibroids & Advocates for Women's Health, NYU Langone Health NewsHubSign up for our FREE Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-pageLearn More and Register for our Feisty 40+ Strong Retreat: https://www.womensperformance.com/strongretreat Learn More and Register for our 2026 Tucson Bike Camp: https://www.girlsgonegravel.com/camp Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Phosis: Use the code FEISTY15 for 15% off at https://www.phosis.com/ Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get 30% offWahoo KICKR RUN: Use the code FEISTY to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/maTzL This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Podcorn - https://podcorn.com/privacyPodscribe - https://podscribe.com/privacy
In today's episode, we passed the mic to Tara E. Seery, MD, who moderated an OncLive Insights discussion on the future of the pancreatic cancer treatment paradigm. Rounding out the discussion with additional expert perspectives were Paul E. Oberstein, MD, and Priyadarshini Pathak, MBBS. Seery is a medical oncologist at the Hoag Family Cancer Institute in Newport Beach, California. Oberstein is an associate professor in the Department of Medicine at the New York University (NYU) Grossman School of Medicine; as well as the director of the Gastrointestinal Medical Oncology Program, the assistant director of the Pancreatic Cancer Center, and the service chief of the Gastrointestinal Medical Oncology Program at NYU Langone's Perlmutter Cancer Center. Pathak is an assistant in medicine at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School in Boston. In this exclusive conversation, Drs Seery, Oberstein, and Pathak highlighted key data from the phase 3 NAPOLI 3 trial (NCT04083235) of NALIRIFOX (liposomal irinotecan, 5-fluorouracil [5-FU], leucovorin, and oxaliplatin) vs nab-paclitaxel (Abraxane) and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma; the toxicity profiles of NALIRIFOX and FOLFIRINOX (leucovorin, 5-FU, irinotecan, and oxaliplatin); real-world data with these regimens, and more.
Comment on the Show by Sending Mark a Text Message.This episode is part of my initiative to provide access to important court decisions impacting employees in an easy to understand conversational format using AI. The speakers in the episode are AI generated and frankly sound great to listen to. Enjoy!What happens when the line between your work and personal life blurs beyond recognition? Five IT professionals at NYU Langone Health System are taking a stand in a legal battle that resonates with countless workers who've found themselves checking emails after hours or staying late without additional compensation.The case centers on a fundamental question: when should technical support professionals receive overtime pay? The plaintiffs—specialists with titles like System Analyst and Desktop Support Technician—claim they routinely worked 42-55 hours weekly without overtime compensation because NYU Langone incorrectly classified them as exempt employees. They argue their primary duties involved routine troubleshooting, ticket management, and technical assistance that lacked the independent judgment typically required for overtime exemption, despite their professional-sounding titles.NYU Langone's vigorous defense includes challenging whether they even fall under federal wage law jurisdiction while simultaneously claiming the employees properly qualified for various exemptions. This highlights how contested the boundaries have become between exempt and non-exempt work in our digital age. Recently, the court conditionally certified a collective action, allowing other similarly situated IT support staff to join the lawsuit—a significant milestone, though not the final word.The implications reach far beyond healthcare IT departments. As technology transforms workplace expectations and responsibilities, many professionals find themselves wondering if their classification accurately reflects their actual duties. This case may help clarify where modern labor law draws the line between work deserving overtime pay and genuinely exempt professional roles. Whether you're questioning your own classification or seeking to understand evolving employment rights, this legal battle offers valuable insights into the changing nature of work and compensation in today's increasingly connected world. Ready to examine your own work arrangement more closely? If you enjoyed this episode of the Employee Survival Guide please like us on Facebook, Twitter and LinkedIn. We would really appreciate if you could leave a review of this podcast on your favorite podcast player such as Apple Podcasts. Leaving a review will inform other listeners you found the content on this podcast is important in the area of employment law in the United States. For more information, please contact our employment attorneys at Carey & Associates, P.C. at 203-255-4150, www.capclaw.com.Disclaimer: For educational use only, not intended to be legal advice.
Some of us dream of being able to say, “Thank you for Coming to my Ted Talk.” Others wilt at the thought of getting on stage to deliver not just a lecture on a complicated or sensitive topic, but a performance. My guest today Dr. Chris Petrilli has delivered. My first Ted Talk alumni on Off the Record (of which I'm aware) recently presented How AI could help doctors detect patterns before a Ted Talk audience. This show delves behind the scenes of a Ted Talk. But it does a lot more: We get deeply into the subject of Chris' talk itself, one I think about all the time—artificial intelligence, how we interact with it, what it means for the future of the mid-revenue cycle (and our humanity), and how AI and humanity can be reconciled. Chris practices internal medicine at NYU Langone where he is also tasked for developing AI solutions for the health system. This is his second appearance on the podcast. On this show we cover: Ted Talk details: How it came about, preparation, and delivery: How many dry runs? Coaching, nerves, and tech assistance Impact of the talk. Humor and entertainment as a teaching tool and effecting change at work (including physician buy-in) How can humanity coexist with this powerful new technology—is Chris an optimist or pessimist or some blend of the two? Pattern recognition: Similarities and differences between humans and machines AI as an overcaffeinated intern, powerful and full of energy but with no idea what's happening... Emerging clinical and mid-revenue cycle applications Watch Chris' Ted Talk on YouTube: https://www.youtube.com/watch?v=M0qIyowPr0E
On today's episode, Dr. Mark Costes sits down with Dr. David Reznik, a pioneering force in public health dentistry and founder of the HIV Dental Alliance. Speaking from the Exhibitor Hall at Thrive Live in Las Vegas, Dr. Reznik shares his decades-long journey in treating HIV-positive patients, his role in establishing the Oral Health Center at Grady Health System, and the critical need for proper infection control in dental offices. He dives into topics from waterline safety protocols and hemoglobin A1C testing to post-exposure prophylaxis and advances in HIV treatment. With over 6,000 HIV patients in care and a leadership role in training the next generation of dentists through NYU Langone's AEGD program, Dr. Reznik brings both clinical expertise and heartfelt advocacy to a conversation every dentist should hear. Be sure to check out the full episode from the Dentalpreneur Podcast! EPISODE RESOURCES linkedin.com/in/david-reznik-ab83522 https://www.truedentalsuccess.com Dental Success Network Subscribe to The Dentalpreneur Podcast
Vi reser till New York för att lära oss om det amerikanska sjukvårdssystemet. I avsnittet möter vi kardiologen Jeffrey S Berger som driver NYU Langone's Center for the Prevention of Cardiovascular Disease. Hosted on Acast. See acast.com/privacy for more information.
Dr. Mosses comes to Maternal Resources after serving as the Medical Director of the OB/GYN department at Ezra Medical Center in Brooklyn, where he built a thriving obstetric practice from the ground up, now averaging over 50–60 deliveries per month. Prior to that, he was a senior attending physician at NYU Langone in Midwood, Brooklyn, where he maintained a cesarean section rate of under 10%—a testament to his skill in supporting vaginal births, including twin deliveries and VBACs (vaginal birth after cesarean). His approach combines clinical rigor with a strong belief in giving patients safe options for physiologic birth. Expertise in Vaginal Twins, VBACs, and Minimally Invasive Surgery Known for his hands-on experience with high-volume deliveries, Dr. Mosses has a deep expertise in managing vaginal twin deliveries and has successfully supported many patients through VBACs. He has performed thousands of deliveries and a wide range of gynecologic surgeries using open, laparoscopic, and vaginal approaches. Whether managing a routine pregnancy or a more complex case, his goal is always the same: to deliver excellent care that respects patient autonomy and promotes healthy outcomes. This commitment perfectly mimmics the core of what Maternal Resources is all about. Training, Awards, and Teaching Excellence Dr. Mosses completed his OB/GYN residency as Chief Resident at Richmond University Medical Center, where he received the Society of Laparoendoscopic Surgeons Award and completed advanced training in gynecologic oncology at Sloan Kettering. He has also supervised and trained residents at multiple academic institutions, including NYU Langone and Lutheran Medical Center. His academic background, combined with his leadership and research accolades, reflects his ongoing commitment to advancing women's health. Dr. A. Jay Mosses has been recognized for his outstanding contributions to the field of obstetrics and gynecology with several prestigious awards. During his residency at Richmond University Medical Center, he was honored with the Society of Laparoendoscopic Surgeons Award, acknowledging his excellence in minimally invasive surgical techniques. Additionally, his research on the use of double balloon cervical ripening catheters in managing massive hemorrhage in cervical ectopic pregnancies earned him the First Place Award at the 2016 Annual Residents' and Fellows' Research Paper Competition. These accolades reflect his commitment to advancing clinical care through both surgical skill and academic research. We're honored to have Dr. Mosses on our team and know our patients will benefit from his skill, warmth, and unwavering dedication to their care. YouTube: Dive deeper into pregnancy tips and stories atyoutube.com/maternalresources . Instagram: Follow us for daily inspiration and updates at @maternalresources . Facebook: Join our community at facebook.com/IntegrativeOB Tiktok: NatureBack Doc on TikTok Grab Our Book! Check out The NatureBack Method for Birth—your guide to a empowered pregnancy and delivery. Shop now at naturebackbook.myshopify.com .
In this episode of BARE IT ALL Coffee Talk, we welcome Katie Sclafani, Licensed Clinical Social Worker and Certified Clinical Transplant Social Worker with the Sala Institute for Child & Family Centered Care at NYU Langone's Hassenfeld Children's Hospital.Katie walks us through the invaluable role social workers play in the pediatric liver disease journey — from diagnosis through transplant and every step in between. As part of the care team, social workers help ensure families are informed, connected to resources, and supported as they navigate complex medical decisions and transitions.Whether you're a caregiver, healthcare provider, or advocate, this conversation offers an important look into how social workers guide and empower families during some of their most challenging moments.Links for organizations mentioned.Ronald McDonald House Charities | RMHCHarboring HeartsFriends of Karen - Friends of KarenLend-A-Hand: Bare Inc.If you or someone you know has experience with biliary atresia and is willing to share your journey publicly to support our initiative, please don't hesitate to contact us at contactus@bareinc.org. Let's amplify our voices and foster understanding together."Connect with us:• Bare Inc.• Instagram• X - Twitter• Facebook• YouTubeIf your child is facing a life-saving liver transplant, please reach out to The Children's Organ Transplant Association, or COTA. The COTA crew looks forward to learning more about your family's Biliary Atresia journey. COTA works with families to lessen the financial burden of a life-saving transplant, and support is provided at absolutely no cost. Please call COTA today at 1-800-366-2682 or visit www.cota.org/getstarted to learn more about how they can help.Music by Magnetic_Trailer from PixabayListen now on Spotify, Apple Podcasts, or wherever you get your shows.#BiliaryAtresia #KasaiProcedure #MedicalJourney #Parenting #BAREItAll #CoffeeTalk
On this episode of The Wholesome Fertility Podcast, I am joined by Dr. Nirali Jain (eggspert_md), a board-certified OB/GYN and reproductive endocrinologist at Reproductive Medical Associates (RMA). Dr. Jain shares her expert insights on fertility preservation for individuals undergoing cancer treatment, a crucial yet often overlooked aspect of reproductive care. We explore what options are available for fertility preservation, including egg and sperm freezing, and why it's so important to initiate these discussions before starting chemotherapy or radiation. Dr. Jain also explains the difference between Letrozole and Clomid, the impact of estrogen-sensitive cancers on IVF treatments, and innovative approaches like random-start cycles and DuoStim protocols. Whether you're facing a cancer diagnosis or simply thinking proactively about your reproductive future, this conversation is filled with knowledge and reassurance. Key Takeaways: Why it's essential to discuss fertility before starting cancer treatment. The role of Letrozole in estrogen-sensitive cancers and fertility preservation. Differences between Letrozole and Clomid, and why Letrozole is often preferred. How new protocols like DuoStim and random-start cycles are improving outcomes. Why fertility preservation is important even for those without a cancer diagnosis. Guest Bio: Dr. Nirali Jain (@eggspert_md) is a board-certified OB/GYN and fertility specialist at Reproductive Medicine Associates (RMA) in Basking Ridge, New Jersey. She earned both her undergraduate degree in neurobiology (with a minor in dance!) and her medical degree from Northwestern University, before completing her residency at Weill Cornell/NYP, where she served as co-Chief Resident, and her fellowship in reproductive endocrinology and infertility at NYU Langone. Deeply passionate about women's health and fertility preservation, Dr. Jain blends the latest research and cutting-edge treatments with compassionate, patient-centered care. Her interests include third-party reproduction and oncofertility, and she is especially passionate about supporting patients navigating fertility preservation through a cancer diagnosis. Outside of the clinic, Dr. Jain is a trained dancer, a dedicated global traveler, and an adventurer working toward hiking all seven continents with her husband. Her diverse experiences, from international medical rotations to personal connections with friends and family navigating infertility, have shaped her into a warm, resourceful, and determined advocate for her patients. Links and Resources: Visit RMA websiteFollow Dr. Nirali Jain on Instagram For more information about Michelle, visit www.michelleoravitz.com To learn more about ancient wisdom and fertility, you can get Michelle's book at: https://www.michelleoravitz.com/thewayoffertility The Wholesome Fertility facebook group is where you can find free resources and support: https://www.facebook.com/groups/2149554308396504/ Instagram: @thewholesomelotusfertility Facebook: https://www.facebook.com/thewholesomelotus/ Disclaimer: The information shared on this podcast is for educational and informational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health or fertility care. -- Transcript: # TWF-Jain-Nirali (Video) [00:00:00] **Michelle Oravitz:** Welcome to the podcast Jain. **Dr. Nirali Jain:** Thanks so much for having me **Michelle Oravitz:** Yeah, so. **Michelle Oravitz:** I'm very excited to talk about this topic, which, um, actually you don't really hear a lot of people talking about, which is how to preserve your fertility if you're going through a cancer diagnosis and if you have to go through treatments. 'cause obviously that can impact a lot on fertility. **Michelle Oravitz:** I have, um, seen actually like a colleague of mine go through. And she also preserved her fertility and, and now she has a baby boy. so it's really nice. **Michelle Oravitz:** to **riverside_nirali_jain_raw-video-cfr_michelle_oravitz's _0181:** so nice. **Michelle Oravitz:** So I'd love for you first to introduce yourself and kind Of give us a background on how you got into this work. **Dr. Nirali Jain:** Of course. Um, so I am Dr. Narly Jane. I am, um, an OB GYN by training, and then I did an additional, after completing four years of residency in OB GYN and getting board certified in that, I did an additional training in reproductive endocrinology and [00:01:00] infertility or otherwise known as REI. So now I'm a fertility specialist. **Dr. Nirali Jain:** Um, I trained at Northwestern in Chicago, so I went to undergrad and medical school there. And then, um, home has always been New Jersey for me, so I moved back out east to New Jersey. Um, I did all my training actually in New York City at Cornell for residency and NYU for fellowship. Um, and then moved to the suburbs. **Dr. Nirali Jain:** Um, and now I'm a fertility specialist in, in Basking Ridge at Reproductive Medical Associates. **Michelle Oravitz:** Very impressive background. That's awesome. **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** I'd love to hear just really. About what your process is. If a person has been diagnosed with cancer, like what is the process? What are some of the things that you address if they are trying to preserve fertility, and what are some of the concerns going **Dr. Nirali Jain:** yeah, yeah. All great questions. So, you know, there's a lot of us, uh, the Reis. Are a very small, [00:02:00] there's a very small number of us. So in terms of specializing in fertility preservation, technically we all are certified to treat patients with cancer and kind of move them through fertility preservation before starting chemotherapy. **Michelle Oravitz:** Mm-hmm. **Dr. Nirali Jain:** Um, luckily we've been working closely with oncologists in the past several years just to establish some type of streamlined system because having a diagnosis of cancer and hearing all that information. Especially when you're young is so hard. So I think that's, that's where my interest started in terms of being able to speak to and counsel cancer patients. **Dr. Nirali Jain:** I think it is a very specific niche that you really have to be comfortable with in our field. Um, I. So I'll kind of walk you through, you know, what it, what does it look like, right? Um, you go into your oncologist's office suspecting that you have this, this lump. I'll take breast cancer, for example. It could really be any kind of cancer. **Dr. Nirali Jain:** Um, but breast cancer in a reproductive age patient or someone that's in those years where you're starting [00:03:00] to think about building a family, planning a family, um, or if you have kids at home, that's usually the type of patient that we see come in with a breast cancer diagnosis. So. Kinda just taking that, for example, um, the minute that you're diagnosed, it's really your oncologist's responsibility to counsel you on what treatment options are going to be offered to you. **Dr. Nirali Jain:** And then based off of the treatment options, it's important to know how that affects your reproduction. So how does it affect your ovaries in the short term, in the long term, um, in any way possible. So. Once a patient is initially referred from their oncologist to myself or any other fertility specialist, they come into my office and we just have a 30 minute conversation really talking about family planning goals. **Dr. Nirali Jain:** Any kids that they've had in the past either naturally conceived or through um, IVF, and then we talk about where they're at in their relationship. Are they married, are they not? Are they with a partner, [00:04:00] a male partner, a female partner, whatever it might be. It's important to know the social standpoint, um, especially in this sensitive phase of life. **Dr. Nirali Jain:** So patient patients usually spend anywhere from 30 minutes to an hour. Um, just kind of talking through where they're at, how they're feeling, what their ultimate childbearing goals are. And then from there we do an ultrasound and that's when I'm really able to see, you know, the, the reproductive status. **Dr. Nirali Jain:** So what do the ovaries look like? What does the uterus look like? Is there something that I need to be concerned about from a baseline GYN standpoint? Um, and all of those conversations are happening in real time. So. I think one of the things is patients come in and they're like, I'm already so overwhelmed with all this information from my oncologist, and now my fertility specialist is throwing all this information at me. **Dr. Nirali Jain:** Luckily, the way I like to frame it is you come in and you just let go. Like you let us do the work because in the background we're the ones talking to your oncologist. We're the [00:05:00] ones giving that feedback and creating a timeline with your oncologist. Um, and really I think just getting in the door is the hardest part. **Dr. Nirali Jain:** So once patients are here to see us, we go through the whole workup. We do anything that we would do for a normal patient that came in for fertility preservation. And then based off of where they're at in their journey, we talk about what makes sense for them, whether that means freezing embryos, freezing eggs, they're very similar in terms of the, the few weeks leading up to the egg retrievals. **Dr. Nirali Jain:** So I have that whole conversation just at the initial visit. And then from there we talk about the timeline behind the scenes and make sure that it works with their lives before moving forward. **Michelle Oravitz:** So for people listening to this, why, and this might be an obvious question, but to some it might not be, **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** why would somebody want to preserve. eggs or sperm. 'cause I've had actually some couples **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** come to me where the husband preserved the sperm and they had to go through IVF just because he was going [00:06:00] through cancer treatments. So he had to preserve the sperm ahead of time. **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** people need to consider doing that before doing cancer treatments? **Dr. Nirali Jain:** So there are certain cancer treatments that do affect the ovaries and the sperm health, and you know, for men and women, it affects your reproductive organs. In a similar way, um, depending on the type of chemotherapeutic agent, there are some that are more dangerous in terms of, um, being toxic to your ovaries or toxic to your sperm. **Dr. Nirali Jain:** And those are the instances where we are really thinking about what's the long-term impact because there's medications that oncologists do give patients, and our oncologists are amazing, the ones that we work with, Memorial Sloan Kettering from Reproductive Medical Associates through RMA, um, and. **Dr. Nirali Jain:** They're just so good at what they do and are so well-trained, so they know in the back of their mind, is this going to impact your ovaries or your sperm health or not? Um, and I [00:07:00] think that any chemotherapy, you know, your ovaries are these, these small organs that are constantly turning over follicles every month. **Dr. Nirali Jain:** So every month we're losing those eggs, and if they don't become. If an egg isn't ovulated, it doesn't become a baby, it's just gonna die off. So I counsel even patients that don't have cancer, I counsel them on fertility preservation as young as possible. You know, between the ages of 28 and 35, that's like the best time to preserve your fertility. **Dr. Nirali Jain:** So in cancer patients, there's an extra level added to that where even if they are a little bit younger, a little bit older. Your eggs are not gonna be the same quality. There's gonna be higher level of chromosomal errors, more DNA breakage, um, and, and bigger issues that lead to issues with conceiving naturally afterwards. **Dr. Nirali Jain:** So I think that it's important to consider how that chemotherapy is going to affect them or how surgery would affect them if it was, for example, a GYN cancer where [00:08:00] we're removing a whole ovary, you know, what, what do we have to do to preserve your fertility in that case? And those are important conversations to have. **Michelle Oravitz:** Yeah. for sure. I know that a lot of people are also concerned, you know, with going through the IVF process, you're taking in a lot of estrogen, a lot of hormones, and many cancers are actually estrogen sensitive. So I wanted to talk to you about that. 'cause I know that the data shows that it's. It's been fine, which some people might find surprising, but I wanted you to address that and just kind of **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** from your perspective. **Dr. Nirali Jain:** That's so interesting that you asked that question because I actually, my whole I I graduated fellowship last year and my entire, like passion project in fellowship was looking at one of the drugs that we use to suppress the estrogen levels specifically in cancer patients. Um, and I had presented this at a few of our reproductive meetings. **Dr. Nirali Jain:** Um, A SRM is one of our annual meetings where all of the reiss get together. A lot of male fertility [00:09:00] specialists come and we kinda just talk about. Specific things and fertility preservation for cancer patients is, has been an ongoing topic of interest for all of us. Um, and it's important to know that there are different medications that we can offer. **Dr. Nirali Jain:** Letrozole is the one that I, um, have a particular love for and I, uh, you know, I use all the time for my patients, um, for different reasons, but it suppresses the exposure that your body has to estrogen. And there's mixed data, um, out there in terms of, you know, does Letrozole suppression actually impact, you know, does it help or. **Dr. Nirali Jain:** Or does it have no impact on your future risk of cancer after treatment? Um, and that honestly is still up for debate. But what we do know is that there's no increased risk of cancer recurrence in patients that have undergone fertility preservation with or without Letrozole. Um, Letrozole is one of those things that we can give, and the way it works is basically. **Dr. Nirali Jain:** It masks that [00:10:00] conversion. It, it doesn't allow for conversion from those androgens in the male hormones over to estrogen. Um, and so your body doesn't really see that estrogen exposure. It stays nice and low throughout your cycle, and it does help with actually ovarian maturation and getting mature eggs harvested and, um, helps a little bit with, with quality too. **Dr. Nirali Jain:** So I think that it's really nice in terms of having that available to us, but know that. It's not, it's not essential that you have it, really, the data showing plus minus. Um, but there are certain things that we can do to protect the ovaries, protect your exposure to estrogen. Um, and so that shouldn't be top of mind of concern when we're going through fertility preservation, even with an estrogen sensitive cancer. **Michelle Oravitz:** Actually, so, uh, on a different topic, kind of going back to that, so Letrozole versus Clomid, I, it's like a, the questions I personally feel just based on what I've heard and like my own research that Letrozole would be kind of like the more. [00:11:00] Um, the, it's, it's a little better, but I know that it really depends on the person as well. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** they might do better with Clom, but I'd love to hear your perspective and kind of pick your brain on this. **Dr. Nirali Jain:** totally. You're choosing all the, all the right questions because these are all of my, my specific interests and niches. So **Michelle Oravitz:** Oh, **Dr. Nirali Jain:** Letrozole is basically, you know, we use Letrozole and Clomid in. Patients that don't have cancer and patients that come in for an intrauterine insemination, that's kind of the most common scenario where we're thinking about, you know, which medication is better? **Dr. Nirali Jain:** Letrozole or Clomid and Clomid used to be the, the most common medication that we use, we dose patients, you know, have 50 milligrams of Clomid, give them five days of the medication. It's an oral pill. Feels really easy and. The way it works is really, it recruits more than one follicle, so it really helps with the release of, um, more than one follicle growing more than one follicle in the ovary. **Dr. Nirali Jain:** Um, but it has a little bit [00:12:00] higher of a risk of twins because that's exactly what it's good at. Um, Clomid, not so much in the cancer. In the cancer front, it's not really used there because it's considered, from a scientific perspective, it's considered like a selective estrogen receptor modulator. So it doesn't necessarily suppress your estrogen levels in the same way that Letrozole does versus. **Dr. Nirali Jain:** Letrozole is an aromatase inhibitor, so it really blocks the chemical conversion of one drug or one hormone to the other hormone. Um, the reason we love Letrozole so much, and I don't mean to like gush over Letrozole, but um, it's a mono follicular agent, so it works really well at recruiting one follicle **Michelle Oravitz:** Mm-hmm. **Dr. Nirali Jain:** you know, every OB-GYN's nightmare in a way is having multiples when you didn't intend on having multiples at all. **Michelle Oravitz:** so **Dr. Nirali Jain:** Um. **Michelle Oravitz:** were saying that, um, there's more of a chance of twins, it's Clomid, not letrozole. **Dr. Nirali Jain:** Yes, there's a higher chance with Clomid versus Letrozole. And I mean, don't get me wrong, there's a chance of twins with [00:13:00] any type of assisted reproductive technology. Even when we're doing single embryo transfers, there's a chance that it's gonna split. So, um, the chance is always there just like it is in the natural world. **Dr. Nirali Jain:** But we know for a fact that. CLO is really good at recruiting many follicles. It's good for certain patients that don't respond well to Letrozole. Um, but Letrozole is kind of our, our go-to drug these days just because of all the benefits that we've seen. **Michelle Oravitz:** Awesome. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** These are all fun things to ask because I, I love talking to our eis 'cause there's so much information that I'm always **Dr. Nirali Jain:** totally. **Michelle Oravitz:** learn a lot from my patients in my own research, but it's really cool. Picking your guys' brains. So another question I have, and I have actually talked to Dr. Andrea Elli, he's been on, **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** and he does a lot of endometriosis and, and immune related work as well, **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** so. I'd love to know just from your perspective. One thing that I do know from, based on what I've heard is that the, [00:14:00] guess like you were just saying, that breast cancer or estrogen sensitive breast cancer doesn't seem to be affected by IVF cycles, however, and endometriosis lesions do get affected. **Dr. Nirali Jain:** Yeah. **Dr. Nirali Jain:** that's a great question. So, you know, every, there are so many complex G mind diagnoses that the, that our patients come in with. Um, and endometriosis is a big one because there is clear data that endometriosis is linked to infertility. So we think about, you know, when a patient comes in with endometriosis, we really do think about the different treatment options and what are the short-term and long-term impacts of the hormones that we're giving 'em. **Dr. Nirali Jain:** Um, these days, again, kind of going back to Letrozole, we, letrozole is something that I give all of my endometriosis patients because it helps suppress their estrogen because we know. **Michelle Oravitz:** interesting. **Dr. Nirali Jain:** is very responsive to estrogen and leads to this dysfunctional regulation of all the endometrial tissue that can really flare in a, [00:15:00] in a cycle, or shortly after a cycle. **Dr. Nirali Jain:** I. So we really, for endometriosis patients, the, the best treatment is being on birth control because we don't see that hormonal fluctuation. The up and down of the estrogen and the progesterone, that's what leads to those flares. Um, so I really, I watch patients closely after their cycles too, because you definitely can have an endometriosis flare and we say the best treatment for endometriosis is pregnancy, right? **Dr. Nirali Jain:** That's when you're suppressed, that's when you're at your lowest. Um, and patients, my endo patients feel so good in pregnancy because they have. Hormones that are nice in that baseline, they're not getting periods of course. Um, and that's truly, truly the best treatment. **Michelle Oravitz:** That's interesting. **Dr. Nirali Jain:** But it is important to consider when you're going through infertility treatments. **Dr. Nirali Jain:** How does my endometriosis affect the short and long-term effects of the fertility medications? And really not to, not to say that they're bad in any way. I think a lot of endometriosis patients go through IVF and have success and do really, really well, and that's kind of the push that they need. [00:16:00] Um, but it's important to be mindful of the bigger picture here. **Dr. Nirali Jain:** It's not just, you're not just a number of. A patient with endo coming in, getting the same protocol. It's really individualized to the extent of your lesions, what symptoms you're having, what grade of endometriosis, where your lesions are. So we're the RAs are thinking about everything before we actually start your protocol. **Michelle Oravitz:** It's crazy how in depth it is, and it's, it, there's just so, it's so multifaceted, **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** when it's females **Dr. Nirali Jain:** totally. **Michelle Oravitz:** are a little, I mean, they can, you know, there, there's definitely a number of things, but it's not as complicated and interconnected **Dr. Nirali Jain:** Exactly. Exactly. That's so true. **Michelle Oravitz:** And so one question I actually have, this is kind of really off topic, but something that I was curious about. **Michelle Oravitz:** 'cause I heard about a while **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** a, a type of cancer treatment that was used. I'm not sure exactly what it was, but for some reason it actually caused follicles to grow, [00:17:00] or to multiply. And they were **Dr. Nirali Jain:** Interesting. **Michelle Oravitz:** this definitely. Puts, um, the whole idea of like a woman being born with all the follicles she'll ever have on its head, I thought that was really Interesting. **Michelle Oravitz:** Now I learned a little bit about it. I don't think it really went further than that, **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** one of those things that they're like, Hmm, this is interesting. I don't know, it was kind of a random side effect of this chemo drug. I dunno if it was a chemo drug or a cancer drug. **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** ever heard of that. **Michelle Oravitz:** So I was just **Dr. Nirali Jain:** I haven't, I mean, that's interesting. I feel like I'd have to look into that because that would be definitely a point of interest for a lot of Reis. But it kind of does go back to the point of, you know, women are really born with all the eggs we're ever gonna have. So it's about a million, and then it just goes down from there. **Dr. Nirali Jain:** And the, by the time you start having periods, I like to kind of show my patients a chart, but you have a couple hundred thousand eggs and you ovulate one egg a month. That's, you know. Able to [00:18:00] progress into a fertilized egg and then into a, an embryo into a baby, um, if that's your goal. But otherwise, patients that are having periods and not trying to actually get pregnant, we're losing hundreds of eggs a month. **Dr. Nirali Jain:** So. **Michelle Oravitz:** Mm. **Dr. Nirali Jain:** It's important to kind of think about that decline, and it's important to know that that rate can be faster in patients with cancer, patients with low ovarian reserve. And sometimes when you have the two compounded, that's when a fertility specialist is definitely, you know, in the queue to, to have a discussion with you in terms of what that means and how you can reach your family building goals despite being faced with that, with that challenge. **Michelle Oravitz:** Yeah. **Michelle Oravitz:** I mean, 'cause we know oxidative stress is one of the things that can cause, uh, **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** quality eggs, but it's also can cause cancer. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** um, similar, you know, like things that really deplete the body could definitely impact. Um, and then what are your thoughts? I know I'm asking you all kinds of random questions, **Dr. Nirali Jain:** I love it. **Michelle Oravitz:** are your thoughts about doing low simulation in certain [00:19:00] circumstances versus high stem? **Michelle Oravitz:** Sometimes people don't respond as well to higher stems. **Dr. Nirali Jain:** Yeah, that's a great point. I think that it kind of all goes back to creating an individualized protocol. If. A patient's going to a practice and basically just getting a protocol saying, this is our standard. We start with our standard of, you know, I, I think about the standard, which is 300 of the FSH or that pen that you dial up, and then 150 units of that powder vial. **Dr. Nirali Jain:** And we have patients mixing powders all the time, and that's kind of our blanket protocol that we give patients. But that's not really what's happening behind the scenes. And if you're given a protocol that's, and being told, you know, this is kind of what we give to everyone, it's probably not the right fit for you. **Michelle Oravitz:** Yeah, I **Dr. Nirali Jain:** Um, there are certain patients that respond to a much lower dose and do really, really well, and then some patients that need a much higher dose. Um, and I think it's, that's kind of like the fun part of being an REI of being able to individualize the [00:20:00] protocol to the patient. Um, and I know for a fact there are so many, luckily, you know, we have so many leaders in REI that have been. **Dr. Nirali Jain:** Have dedicated their entire careers to researching these different protocols and how they can help different patients. Um, patients with lower a MH, you know, might benefit from a duo stim protocol, for example. That's kind of the first one that comes to mind, but a protocol where we're using those follicles from the second half of a cycle. **Dr. Nirali Jain:** I would've never thought that those were the follicles that **Michelle Oravitz:** Oh, **Dr. Nirali Jain:** would be better than the first half of the cycle, **Michelle Oravitz:** Wait, **Dr. Nirali Jain:** but, **Michelle Oravitz:** that. Explain that. Um, because I think that that's kind of a unique **Dr. Nirali Jain:** mm-hmm. **Michelle Oravitz:** that I haven't heard of. **Dr. Nirali Jain:** Yeah, so there's this new day. It's still kind of developing, but um, kind of going back to, you know, what's an individualized protocol? Duo STEM is one of the newer protocols that we've started using. I, I've used it once or twice in patients. Um, but it goes back to the research that shows that you might actually have two different periods of time in a menstrual cycle where you could potentially recruit [00:21:00] follicles. **Dr. Nirali Jain:** You could have a follicular phase where there's a certain cohort of follicles recruited, and then you have a follicle that forms creates a corpus glut. **Michelle Oravitz:** um, protocols **Dr. Nirali Jain:** Yep. And then you basically go through the follicular protocol and then a few days after a retrieval, instead of waiting for a new follicular cohort or follicular recruitment from the first half of your menstrual cycle, you actually use the luteal phase and you recruit those follicles that would've actually died off or have been prematurely recruited in a prior cycle. **Dr. Nirali Jain:** So **Michelle Oravitz:** that's So **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** you just do a similar, I guess, um, medicine, **Dr. Nirali Jain:** go right back into it. **Michelle Oravitz:** do the same exact thing, but right after ovulation. **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** Fascinating. That's really interesting. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** has been your experience with that? **Dr. Nirali Jain:** I think it's, honestly, it's mixed. Um, so far, you know, our data from fertility and sterility and A SRM, it, it shows support for these DUO STEM [00:22:00] protocols, saying that if patients don't have that great quality of eggs or if they have a very low number, maybe they'd benefit from starting the meds earlier and recruiting follicles. **Dr. Nirali Jain:** A little bit earlier. Um, so we've seen positive results so far. A lot of work to be done in terms of really understanding it. Um, and of course, as a new attending, I have a lot more experience to kind of build on. Um, but I, I have seen success from it. **Michelle Oravitz:** That's fascinating. Are there any other new technologies, like new add-ons, um, that you've seen, that you've found to be really cool or interesting? **Dr. Nirali Jain:** I think the biggest thing, actually, kind of going back to our whole topic for today is fertility preservation cancer patients. One of the biggest things that I've learned recently is that we used to start fertility, um, patients. You know, only in the beginning of the cycle days, two or three is technically like when most. **Dr. Nirali Jain:** Most clinics, um, start patients, but for our cancer patients, sometimes you don't have that time. You don't wanna wait a full month to [00:23:00] restart, um, your, you know, your menstrual cycle and then do the fertility preservation and then delay chemotherapy a full month. So we started doing what we call random starts. **Dr. Nirali Jain:** So you basically start a patient whenever they come in. You know, it could be the day after your consultation, the day of your consultation. I've kind of seen all of the above. Um, and we've seen really good success with random starts, per se. Um, and we've been doing a lot more of that, where it's not as dependent on where you're at in your cycle. **Michelle Oravitz:** Mm-hmm. **Dr. Nirali Jain:** Um, obviously there's a difference in outcomes. You might not be a great candidate for it, so definitely it's worth talking to your doctor about it. But it kind of gives relief to our cancer patients where if you have a new cancer diagnosis and you're like, oh, I just finished my period, like, I can't even start a cycle until next month. **Dr. Nirali Jain:** That's not always true. Um, so it's always worth it to go into see a fertility specialist and just get, you know, get the data that you need right away, and then you can make a decision later on. **Michelle Oravitz:** For sure. Um, Yeah. **Michelle Oravitz:** and I wanted to kind of cover a lot of different topics 'cause I know that [00:24:00] some people are gonna wanna hear what you have to say that don't necessarily, or, uh, have cancer. But it is important. I, I think that, you know, if you get to thirties and you haven't gotten married or you don't have a partner, I think it's really important to preserve your fertility in general. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** important thing. And then if you were going through a cancer diagnosis and you decided to preserve your fertility, um, guess more for women because they're eventually going to be thinking about transfers after they go through treatment. So what are some of the things that they would need to consider as far as that goes? **Michelle Oravitz:** Like after the **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** then they go through the cancer treatments. Um, and then what, how long should they **Dr. Nirali Jain:** yeah. Like what does it look like? So I've had patients that come back, you know, in my fellowship training I did a, a couple research projects on patients that came back to pursue an embryo transfer, um, after chemotherapy agent. And basically compared them to how they did, um, [00:25:00] compared to patients that didn't have cancer and just froze their embryos or froze their eggs and then came back to pursue a transfer and. **Dr. Nirali Jain:** I think the, the most reassuring thing from the preliminary data that we have is saying that there's no difference in pregnancy rates and no difference in life birth, **Michelle Oravitz:** Awesome. **Dr. Nirali Jain:** of whether they had chemotherapy or not. After freezing those eggs and going through fertility preservation. **Michelle Oravitz:** Amazing. **Dr. Nirali Jain:** Um, in terms of where your body needs to be, I think the oncologist, we, we wait for their green light. **Dr. Nirali Jain:** We wait for their signal to say, you know, she's safe to carry a pregnancy. **Michelle Oravitz:** Mm-hmm. **Dr. Nirali Jain:** And then once we do that, we basically treat you like any other patient. So if you're coming in for a cycle, if you're having periods, then it's reasonable to try a natural cycle protocol, wait for your body to naturally ovulate an egg. **Dr. Nirali Jain:** And instead of obviously hoping that egg will fertilize, we, um, use a corpus luteum. We use the progesterone from the corpus luteum to really support this embryo being implanted into the uterus. Um. Yeah. [00:26:00] And then there's also another side. I mean, some patients don't get their periods back and they always ask like, what if I never get my period back? **Dr. Nirali Jain:** What if I'm just like in menopause because of the chemotherapy agents? And for that, we can start you on a synthetic protocol or basically an estrogen dependent protocol where you take an estrogen pill for a certain number of days. We monitor your lining, then we start progesterone, um, to support your hormones from that perspective instead of relying on your ovaries to release the progesterone that they need, um, and then doing the embryo transfer a few, few days after progesterone starts. **Dr. Nirali Jain:** So there's definitely different protocols depending on where your menstrual health is at after the chemotherapy or after the cancer treatment. Um, but it's important to kind of just know that. That there's options. It doesn't mean that it's the end of the road if you all of a sudden stop getting your period. **Michelle Oravitz:** Yeah, for sure. I mean, 'cause you, technically speaking, you can really control a lot of that. More so for transfers **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** Retrievals really is kind of like what [00:27:00] eggs you have, what the quality is. But people can be in complete menopause and you guys can still control their cycles for transfer, which is kind of. A huge difference **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** in the **Dr. Nirali Jain:** exactly. That's exactly right. Yeah. **Michelle Oravitz:** interesting. Any other, um, new, new things that you're, you guys are excited about? I always like to hear about like the new and upcoming things **Dr. Nirali Jain:** Of course. **Michelle Oravitz:** actually before, which I thought was fascinating. Yeah. **Dr. Nirali Jain:** I feel like there's always like updates and, and new data and things like that coming out, but just know, I think it's important for patients to know, like we're constantly, we're, the reason I chose to even pursue this field was because it's new. Right. There's something that we are discovering every day, every year, and that's what makes our, our conferences so important to attend, um, to really just stay up to date. **Dr. Nirali Jain:** Um, but we are, uh, constantly updating our embryology standards, the way we thaw our eggs, and the success rate associated with a thaw and [00:28:00] how we treat our embryos and the media that we use, right? Like, so we're really thinking about the basic science perspective every single day, and that's what makes this field so unique. **Michelle Oravitz:** It is really awesome. And so do you guys specialize specifically on, um. Egg freezing and, and I mean specific fertility preservation in patients that do that have cancer that are going through treatments, do you guys specialize specifically in that? I mean, I know you do range **Dr. Nirali Jain:** Yeah. Yeah, because it's such a small community, we all have our own niches and we all kind of have our own interests and **Michelle Oravitz:** Yeah. **Dr. Nirali Jain:** no like specific training. There are a couple courses that you take that I took in in training as well, just to kind of understand what it sounds like to, I. Council of fertility preservation, patient with and without cancer. **Dr. Nirali Jain:** Um, and then, you know, you kind of just learn by experience and you form a niche for something that you're passionate about. 'cause that's what makes you, you know, really thorough in, in your treatment. [00:29:00] So that's one of my interests. Um, and, but I would say, **Michelle Oravitz:** training for that. It's just like **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** just know how to treat that in **Dr. Nirali Jain:** exactly. **Michelle Oravitz:** especially if you're interested in doing that. **Dr. Nirali Jain:** Exactly. That's exactly right. It's kind of, it just comes with the experience comes with your mentors and who you're surrounded by, and everyone kind of helps each other get to that point. But there are several specialists in our practice at RMA that specialize specifically in fertility preservation in cancer patients. **Dr. Nirali Jain:** So we have a close communication with our oncologist and they know who to refer to within the practice because everyone has their own little interests. **Michelle Oravitz:** Amazing. **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** Um, definitely. I, like I said, I really enjoy picking your brain because it's a lot of fun for me. I, I do **Dr. Nirali Jain:** Totally. **Michelle Oravitz:** acupuncture, so **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** and I, I think that it's just so crazy that our fields don't work together. I mean, we kind of do, but I think, I just feel like it would be so great **Dr. Nirali Jain:** exactly.[00:30:00] **Michelle Oravitz:** the expertise because you guys have immense. Benefits like in, in, uh, technology and incredible innovations and, and then the natural aspect of really understanding the, the body. And I, I just think that it would work so amazing together if it was more of like a thing. 'cause it, I know in China they actually combine the two **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** eastern. **Dr. Nirali Jain:** Yeah, I mean I think that that's so important and there is data that shows, you know, there's actually a recent study that came out just a few weeks ago on the benefits of acupuncture for fertility patients. And we know that, I mean, I recommend it to all of my patients, specifically the day of the embryo transfer. **Dr. Nirali Jain:** We, luckily, we offer it on site at RMA and we have acupuncturists that come in and, and do a session before and after the embryo transfer, and I think. A lot of that is targeted towards stress relief. But I also think that holistically it's important to feel at your best when we're doing something that's so crucial to your, to your health. **Dr. Nirali Jain:** So to really focus on the diet, focus on stress relief, [00:31:00] focus on meditation, yoga, whatever it takes to get to your best wellbeing when you're going through fertility treatments, um, is so important. So I appreciate **Michelle Oravitz:** Mm-hmm. **Dr. Nirali Jain:** like you that really specialize in the other side of. Of this, because I do consider it still part of the holistic medicine that we need to really maximize success for our patients. **Michelle Oravitz:** Awesome. Well, **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** Jane, this is such a pleasure Of talking to you. You've given us some, so much great information and we've definitely dived into a, do a topic that I don't typically, I haven't yet spoken about. But, um, that being said, it's such an important topic to talk about. And thank you so much for coming on today. **Michelle Oravitz:** Oh, **Dr. Nirali Jain:** course. **Michelle Oravitz:** I get off, how can people find you? **Dr. Nirali Jain:** That's a great question. So I have, um, a social media page. I, it's called Expert nc. So like EGG, **Michelle Oravitz:** I **Dr. Nirali Jain:** um, expert nc. Try, tried to make it a little bit humorous. Um, but I'm all over social [00:32:00] media and would love to hear from anyone that is listening. I, you know, every, every day I get different, um, dms and I'm happy to respond. **Dr. Nirali Jain:** I love hearing about everyone else's. Stories and things like that. Um, so that is kind of my main, main social media platform. Um, and then through like RMA and Reproductive Medical Associates, we also have a YouTube channel. We have an Instagram page, um, of our office available, um, as well that is public. **Dr. Nirali Jain:** So you can find us pretty easily if you just kind of hit Google. But um, yeah, I'm kind of developing my social media platform as the expert and I hope it grows. **Michelle Oravitz:** Love it. Great. **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** was such a pleasure talking to you. Thank you. so much **Dr. Nirali Jain:** Thank you. **Michelle Oravitz:** today. **Dr. Nirali Jain:** Of course. Thank you so much for having me. [00:33:00]
In this episode of The No Normal Show, Desiree Duncan and Chris Bevolo highlight the cultural crossfire brands are navigating today. From Nike's controversial “Never Again” billboard to NYU Langone's controversial Super Bowl ad, they explore how even well-intentioned moves can result in backlash in a world of unapologetic commentary and hypersensitive audiences. Fresh from his recent Becker's and HMPS panels to duo recap conference trends and topics — highlighting AI disruption and the marketing ROI challenge that just won't go away. For healthcare marketers trying to lead bold while avoiding missteps, this episode is for you.Subscribe to The No Normal Rewind, our newsletter featuring a mashup of the boldest ideas, sharpest takes, and most rewind-worthy moments from our podcast — right here.
Dr. Christina Prescott, an ophthalmologist at NYU Langone and ocular expert, is helping patients get amazing results from new technologies in lenses. In this episode, Dr. Prescott dives into this under-discussed subject, unveiling the fascinating science behind the eye, and the do’s and don'ts of caring for your own. Screen time, sun protection, diet – which factors really matter? Tune in to learn!See omnystudio.com/listener for privacy information.
How could a single psychedelic treatment cause lasting change? Joshua Siegel, MD, PhD, is on a mission to find out. A leading expert on neuroimaging and neuropsychopharmacology at NYU Langone's Center for Psychedelic Medicine, Dr. Siegel unpacks how psilocybin may spark neuroplasticity and reshape the depressed brain. He also gives us an inside look at the race to develop non-hallucinogenic psychedelic analogs. Dr. Siegel is an assistant professor at NYU Grossman School of Medicine.
What if a simple conversation in the emergency room could reveal who's most at risk for PTSD before symptoms even begin? Katharina Schultebraucks, PhD, shares her innovative work on using machine learning to forecast mental health outcomes and explains how AI could revolutionize how we detect, prevent, and treat psychiatric disorders. Dr. Schultebraucks is Co-Director of the Computational Psychiatry Program and Associate Professor in the Department of Psychiatry and Population Health at NYU Grossman School of Medicine.
With clinician-informaticist collaboration, enterprise-wide governance, and a deep bench of automation use cases, NYU Langone Health is pushing the boundaries of robotic process automation and agentic AI. When a bot at NYU Langone Health identifies a medication reconciliation gap, it doesn't just log an alert. It initiates a secure chat among the attending physician, quality […] Source: NYU Langone Builds Bot-Powered Playbook for Clinical Transformation on healthsystemcio.com - healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
In this episode of Toxic Free with KB, I sit down with the amazing Dr. Judith Joseph! She's a Board-Certified Psychiatrist, clinical assistant professor at NYU Langone, and Chair of the Women in Medicine Initiative at Columbia University. She is the author of the highly anticipated book, “High Functioning: Overcome Your Hidden Depression and Reclaim Your Joy” that was released on April 8th!We go in-depth on what depression really is, how high-functioning depression and anxiety affect our daily lives, and the impact of toxic stress on mental and physical health. She shares insights on breaking unhealthy family patterns, recognizing emotional toxicity in relationships, and practical strategies for managing stress in today's high intensity world!More on Dr. Judith Joseph:Website: https://drjudithjoseph.com/Book: https://highfunctioningbook.com/Instagram: https://www.instagram.com/drjudithjoseph/Follow Us on Instagram: @ToxicFree.KB: https://www.instagram.com/toxicfree.kb/ Follow Us on TikTok: @toxicfreewithkb: https://www.tiktok.com/@toxicfreewithkb Shop some of my favorite products I use everyday!
32: Subway Sanitation, Hochul's Reparation Folly, Albany's Criminal Coddling Democrats, NYU-Langone's Transgender Kerfuffle & Musk's Dangerous Takeover of Treasury's Payment Systems.Welcome to episode thirty-two of David & Stu… Unhinged! As always, we'd like to thank Clara Wang for creating the fantastic artwork for this podcast. In this episode, David and Stu cover the following:1) Stu's encounter with a young lady on the subway on her way to school clipping her nails but redeeming herself by not littering;2) Kathy Hochul's reparation committee and the outrageousness of making any such payments when slavery ended 150 years ago and the victims of which are long dead;3) Albany liberals refused to reform NY's criminal justice reform laws even when asked to do so by state district attorneys, including the pro-criminal Manhattan DA, fat Alvin Bragg.4) NYU-Langone Medical Center's refusal to perform gender-affirming surgery on minors due to Trump's executive order, which threatens to pull funding of providers performing such procedures; and5) Trump's dangerous decision to allow Elon Musk access to US Treasury payment systems could potentially jeopardize our national security and finances since Musk has no legal authority to assume this role or much oversight.Connect with David & Stu: • Email David & Stu: davidandstuunhinged@gmail.com and share your comments, concerns, and questions.The views expressed on air during David & Stu... Unhinged! do not represent the views of the RAGE Works staff, partners, or affiliates. Listener discretion is advised.
In our March episode, we marked Colorectal Cancer Awareness Month with Dr. Renee Williams, a Gastroenterologist and Associate Professor of Medicine at NYU Langone. Dr. Williams talked about the importance of preventive screening for colorectal cancer and walked us through the colonoscopy procedure. In this month's Key Note, she explains what happens if polyps are found during a colonoscopy, what they are and how they're treated. The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. If you're 45 or older (or have risk factors), make an appointment with your primary care physician to talk about which screening is best for you. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on managing stress, building healthy meals and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Renee Williams, MD, MHPE, is a Professor of Medicine in the Division of Gastroenterology at NYU Grossman School of Medicine. Within the Department of Medicine, she is the Associate Chair for Health Equity and the Director of the Saul Farber Program in Health Equity. Institutionally, she is Graduate Medical Education Pillar Lead for NYU Langone's Institute for Excellence in Health Equity. Her interests include health disparities in colorectal cancer screening and medical education with a focus on simulation education. She is a member of the Association of American Medical Colleges' MedEdSCHOLAR Steering Committee, Co-Chair of the New York Citywide Colorectal Cancer Coalition (C5) Risk assessment and Screening Committee, and section editor for the American Society for Gastrointestinal Endoscopy's GESAP (Gastrointestinal Endoscopy Self-assessment Program). She also served on the Board of Trustees for the American College of Gastroenterology from 2018 to 2024.
Egg prices continue to be a pain point for American consumers, as experts say the rise in egg carton costs in January and February are just the beginning of a trend in coming months. The avian flu has been forcing farmers to kill all of their chickens if just one of the birds in their flock is sick with the bird flu. The Department of Agriculture has paid over $1 billion since 2020 to help egg producers who had to cull their flock due to the avian flu. Nebraska Governor Jim Pillen explains what farmers are doing to combat this crisis and continue feeding America. Health and Human Services Secretary Robert F. Kennedy Jr. has been promoting the "Make America Healthy Again" agenda since assuming his position nearly a month ago. During this time, he has focused on improving the nation's diet and emphasized the need for Americans to be better informed about their health. FOX News Senior Medical Analyst and Professor of Medicine at NYU Langone joins to discuss his recent interview with RFK Jr., the importance of being well-informed, and to reflect on the fifth anniversary of the COVID-19 pandemic. Plus, commentary by FOX News Contributor and member of the Wall Street Journal Editorial Board, Bill McGurn Learn more about your ad choices. Visit podcastchoices.com/adchoices
Egg prices continue to be a pain point for American consumers, as experts say the rise in egg carton costs in January and February are just the beginning of a trend in coming months. The avian flu has been forcing farmers to kill all of their chickens if just one of the birds in their flock is sick with the bird flu. The Department of Agriculture has paid over $1 billion since 2020 to help egg producers who had to cull their flock due to the avian flu. Nebraska Governor Jim Pillen explains what farmers are doing to combat this crisis and continue feeding America. Health and Human Services Secretary Robert F. Kennedy Jr. has been promoting the "Make America Healthy Again" agenda since assuming his position nearly a month ago. During this time, he has focused on improving the nation's diet and emphasized the need for Americans to be better informed about their health. FOX News Senior Medical Analyst and Professor of Medicine at NYU Langone joins to discuss his recent interview with RFK Jr., the importance of being well-informed, and to reflect on the fifth anniversary of the COVID-19 pandemic. Plus, commentary by FOX News Contributor and member of the Wall Street Journal Editorial Board, Bill McGurn Learn more about your ad choices. Visit podcastchoices.com/adchoices
Egg prices continue to be a pain point for American consumers, as experts say the rise in egg carton costs in January and February are just the beginning of a trend in coming months. The avian flu has been forcing farmers to kill all of their chickens if just one of the birds in their flock is sick with the bird flu. The Department of Agriculture has paid over $1 billion since 2020 to help egg producers who had to cull their flock due to the avian flu. Nebraska Governor Jim Pillen explains what farmers are doing to combat this crisis and continue feeding America. Health and Human Services Secretary Robert F. Kennedy Jr. has been promoting the "Make America Healthy Again" agenda since assuming his position nearly a month ago. During this time, he has focused on improving the nation's diet and emphasized the need for Americans to be better informed about their health. FOX News Senior Medical Analyst and Professor of Medicine at NYU Langone joins to discuss his recent interview with RFK Jr., the importance of being well-informed, and to reflect on the fifth anniversary of the COVID-19 pandemic. Plus, commentary by FOX News Contributor and member of the Wall Street Journal Editorial Board, Bill McGurn Learn more about your ad choices. Visit podcastchoices.com/adchoices
Let's face it, no one says, “I can't wait to have a colonoscopy!” But with advances in the procedure and easier prep solutions – as well as less-invasive options – there really is no reason to wait to schedule this screening. To mark Colorectal Cancer Awareness Month, we are joined by Dr. Renee Williams, a Gastroenterologist and Associate Professor of Medicine at NYU Langone, who wants everyone to know that colon cancer is preventable, treatable and beatable! Dr. Williams explains risk factors, symptoms and the importance of prevention. She also walks us through the procedure and even shares her own, very candid experience about her first screening. The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. If you're 45 or older (or have risk factors), make an appointment with your primary care physician to talk about which screening is best for you. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on managing stress, building healthy meals and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Renee Williams, MD, MHPE, is a Professor of Medicine in the Division of Gastroenterology at NYU Grossman School of Medicine. Within the Department of Medicine, she is the Associate Chair for Health Equity and the Director of the Saul Farber Program in Health Equity. Institutionally, she is Graduate Medical Education Pillar Lead for NYU Langone's Institute for Excellence in Health Equity. Her interests include health disparities in colorectal cancer screening and medical education with a focus on simulation education. She is a member of the Association of American Medical Colleges' MedEdSCHOLAR Steering Committee, Co-Chair of the New York Citywide Colorectal Cancer Coalition (C5) Risk assessment and Screening Committee, and section editor for the American Society for Gastrointestinal Endoscopy's GESAP (Gastrointestinal Endoscopy Self-assessment Program). She also served on the Board of Trustees for the American College of Gastroenterology from 2018 to 2024.
In this special live episode of Derms and Conditions, recorded at the 2025 Winter Clinical Dermatology Conference - Hawaii®, host Dr James Q. Del Rosso welcomes Dr April Armstrong, chief of dermatology at UCLA, and Dr David Cohen, dermatologist at NYU Langone, to break down the key takeaways from this year's meeting. The discussion kicks off with chronic hand eczema, a condition that can be difficult to diagnose and treat due to its multiple causes. Dr Cohen highlights emerging data on new treatment options, including dupilumab, topical JAK inhibitors like ruxolitinib, and upcoming therapies like delgocitinib. They explore whether these newer therapies could be effective across different causes of hand eczema, even when an allergen isn't clearly identified. Dr Armstrong then shifts the conversation to the next frontier in psoriasis treatment, including new oral therapies that are pushing efficacy to higher levels. They discuss IL-23 receptor antagonists, IL-17 inhibitors, and TNF inhibitors in development, as well as 5-year safety and efficacy data for deucravacitinib, which shows no long-term need for routine monitoring. The group also tackles the evolving treatment landscape for hidradenitis suppurativa (HS), where combination therapy is emerging as a key strategy. Dr Armstrong shares insights into guidance from the HS Foundation and the potential of pairing JAK inhibitors with IL-17 or TNF inhibitors for refractory cases. They wrap up with practical pearls from the conference, including extended terbinafine treatment durations for fungal infections, pediatric biologic use around live vaccines, and the latest treatment options for molluscum contagiosum. Tune in to this information-packed episode for expert insights and clinical updates straight from Winter Clinical 2025!
In this episode of Grow Everything, Karl and Erum sit down with Dr. Glennis Mehra, the absolute powerhouse behind BioLabs at NYU Langone, to talk about what it really takes to build a biotech startup in New York City. From how to deal with imposter syndrome to finding funding in a capital-constrained world, Glennis shares hard-earned insights on how founders can survive (and thrive) in one of the toughest, most exciting biotech ecosystems on the planet. They get into the magic of founder-to-founder collaboration, why biology's complexity is finally getting the respect it deserves, and whether AI is about to make lab work obsolete (spoiler: it's not). Plus, Erum debates whether traveling to Mars just to eat lettuce is worth it.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at www.messaginglab.com/groweverything Chapters: 00:00:00 – Introduction and Vision for a Better Future 00:00:17 – Unexpected Weather, Birthday Trips, and Giant Malls 00:01:41 – Climate Change, Extreme Weather, and the Reality of Rising Temperatures 00:03:07 – Space Travel, Microbes on Mars, and the Lettuce Dilemma 00:05:12 – Biotech Innovations, Soil Microbiomes, and Engineering Nature 00:07:06 – The Storytelling Gene: Why Scientists Must Be Great Communicators 00:09:02 – Sweet Proteins, Strategic Narratives, and Startup Success 00:10:39 – Young Innovators, Biochar, and Climate Tech Disruptors 00:13:12 – Welcoming Dr. Glennis Mehra: The Biotech Builder 00:15:04 – From Academia to Entrepreneurship: Glennis' Journey 00:17:31 – Imposter Syndrome in Biotech: Why Founders Struggle 00:19:55 – The Secret to Building a Strong Startup Community 00:22:18 – The Founder's Dilemma: Making Big Decisions Quickly 00:25:09 – Why Founder-to-Founder Collaboration is Biotech's Superpower 00:28:46 – Capital Scarcity and the Rise of Smarter Founders 00:32:53 – Building a Biotech in NYC: The Reality Check 00:33:42 – The Toughest Part: Capital, Talent, and Space 00:36:09 – Why NYC is a Risk-Taker's Playground 00:38:56 – The Future of Biotech and the AI Acceleration 00:44:29 – Honest Advice for Biotech Entrepreneurs 00:48:12 – BioLabs and the Startup Survival Toolkit 00:52:48 – Final Words and What Comes NextLinks and Resources: Biolabs@NYULangone NASA Science Payloads Researchers link a gene to the emergence of spoken language Oobli and Ingredion Announce Partnership as Demand for Sweet Proteins Accelerates Sweet Dreams Are Made of Proteins: Oobli's Ali Wing A 16-year-old (Harper Moss) helms this new regenerative farming startupTopics Covered: Biotech, Business, NYC, Innovation, Incubator, Accelerator, Startups, BiomanufacturingHave a question or comment? Message us here:Text or Call (804) 505-5553 Instagram / Twitter / LinkedIn / Youtube / Grow EverythingEmail: groweverything@messaginglab.comMusic by: NihiloreProduction by: Amplafy Media
Dr. Wilfried Ellmeier is a Co-Chair of the Scientific Planning Committee at the International Union of Immunological Societies (IUIS) and Professor of Immunobiology and Head of the Institute of Immunology at the Medical University of Vienna. Dr. Laurence Zitvogel is a Keynote Speaker at IUIS 2025 and a Professor and Group Leader at Gustave Roussy. Dr. Dan Littman is also a Keynote Speaker at IUIS 2025 and Professor of Cell Biology and Helen L. and Martin S. Kimmel Professor of Molecular Immunology at NYU Langone. This episode features a discussion on the upcoming IUIS 2025 Congress taking place August 17-22 in Vienna, Austria. They talk about what to expect at the meeting, highlights from this year's program, and where to explore in Vienna.
News outlets are reporting that NYU Langone is cancelling some appointments for gender-affirming care for transgender children -- and that other hospital systems have removed mentions of gender-affirming care from their websites after President Trump issued a related executive order. Caroline Lewis, health care reporter for WNYC/Gothamist, reports on how trans kids and their families are reacting and the New York attorney general's warning to hospital systems that not providing the care would run afoul of state laws.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD Patients with inflammatory bowel disease (IBD) can experience a variety of extraintestinal manifestations (EIMs), including joint and eye pain and skin rashes. Dr. Peter Buch sits down with Dr. David Hudesman to discuss the impacts of these EIMs and explore best practices for patient management. Dr. Hudesman is a Professor of Medicine at NYU Grossman School of Medicine and Co-Director of NYU Langone's Inflammatory Bowel Disease Center.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD Patients with inflammatory bowel disease (IBD) can experience a variety of extraintestinal manifestations (EIMs), including joint and eye pain and skin rashes. Dr. Peter Buch sits down with Dr. David Hudesman to discuss the impacts of these EIMs and explore best practices for patient management. Dr. Hudesman is a Professor of Medicine at NYU Grossman School of Medicine and Co-Director of NYU Langone's Inflammatory Bowel Disease Center.
For centuries, death has been seen as a final, inescapable line—a moment when the heart stops and the brain ceases to function. But revolutionary research asks: What if everything we thought we knew about death was wrong?Sam Parnia, an associate professor of medicine at NYU Langone, is the author of Lucid Dying: The New Science Revolutionizing How We Understand Life and Death. His groundbreaking work explores how science is pushing the boundaries of life and death, uncovering the potential to resuscitate animals—and maybe one day humans—after they've been declared dead. From recalling experiences of consciousness after death (what some call “near-death experiences”) to using AI and advanced techniques to study the brain in its final moments, he explores the profound implications for medicine, ethics and our understanding of what it means to be alive.
Ep. 13 Teaching the Future of Spine: Research, Motion Preservation, & Improving Care, Jeffrey A. Goldstein, MD In this episode of The Spine Pod, co-hosts Courtney Schutze and Brady Riesgraf sit down with Dr. Jeffrey A. Goldstein, a globally recognized expert in orthopedic spine surgery and Director of the Spine Surgery Fellowship and Education programs at NYU Langone. With over 30 years of clinical and research experience, Dr. Goldstein is a staunch advocate for conservative, patient-first treatment plans. His patient-centered philosophy focuses on functional outcomes and prioritizing long-term health of every patient he treats. Dr. Goldstein also discusses his commitment to ongoing innovation, especially in the area of motion preservation. Dedicated to advancing the field, he takes on a dual role as a pioneer in new technologies and a teacher, training residents and fellows in the latest techniques to carry his patient-first legacy forward. He has been a key leader across multiple clinical studies, including being a trainer for both cervical and lumbar artificial discs in the commercialization of ProDisc, as well as being the national PI for 3Spine's MOTUS Lumbar Total Joint Replacement IDE study. In addition to motion preservation, Dr. Goldstein continues to drive patient-care forward through the use of supplementary emerging technologies, including minimally invasive surgery (MIS) and robotics. In this episode, listeners will learn about: The history of how spine care has changed over the past 30 years The entire function spinal unit, and the role of the facets and the disc in the mobility and stability of the spine How motion preserving technologies are becoming mainstream options for treating leg and/or back pain in the correctly indicated patient The convergence of enabling technologies, and how MIS, robotics, and motion preserving implants are coming together to improve patient outcomes The importance of conservative care and exhausting non-operative treatment options prior to receiving spine surgery Where the future of spine care is headed and the newest technologies entering the spine market Dr. Goldstein has been a leading surgeon across the spine industry for more than 20 years, being recognized as a top doctor in America by multiple institutions, including Castle Connolly, New York Magazine, Becker's, and Newsweek. Aside from being recognized by sources and peers, he has also been the past president of ISASS, one of the largest spine conferences in the world, and also holds the title of professor of both orthopedic and neurosurgery at the NYU Grossman School of Medicine. With his accolades in teaching, leadership, and innovation, Dr. Goldstein has had a remarkable impact across the spine community since his inception into medicine. This episode explores how Dr. Goldstein's work has not only shaped his practice but also the broader field of spine surgery, primarily through his dedicated contributions to motion preservation and patient-centered innovations. Whether you're a provider, patient, or industry professional, this episode provides vast insights into the technologies improving patient outcomes and what's on the horizon for the future of spine surgery. Learn more about Dr. Goldstein and NYU Langone Health: Website: https://www.spinesurgerydoctor.com/ LinkedIn: https://www.linkedin.com/in/jeffrey-a-goldstein-md-facs-faoa-917b5b7/ You can find The Spine Pod on all Podcast Streaming Platforms, including: YouTube: / @thespinepod Spotify: https://open.spotify.com/show/0DBzWfV... Apple Podcasts: https://podcasts.apple.com/us/podcast... Amazon Music: https://music.amazon.com/podcasts/98f... iHeart Radio: https://www.iheart.com/podcast/269-th... Follow The Spine Pod on Facebook to learn more about the latest episodes and happenings in the world of motion preservation: https://www.facebook.com/profile.php?...
In this highly requested episode, Dr. Geo sits down with Dr. Vikram Rajpurohit, a clinical professor at NYU Langone and an expert in Prostate Artery Embolization (PAE), to dive into the specifics of PAE as a treatment for Benign Prostatic Hyperplasia (BPH). Dr. Rajpurohit explains what PAE is, how it works, and who the ideal candidates are. The discussion covers the procedure's effectiveness in shrinking the prostate and improving urinary symptoms, along with details on expected outcomes, duration, and what patients should consider when choosing between PAE and other treatments.Key Points:Overview of PAE as a minimally invasive alternative to surgery for BPHThe science behind how PAE works and its impact on prostate and urinary healthInsights into patient outcomes, including prostate shrinkage and symptom improvementComparison of PAE with other common BPH treatmentsCandidacy factors for PAE and important questions for patients to askListen in to learn if PAE might be the right choice for you or a loved one facing prostate-related urinary issues.----------------
What is ‘pink cocaine'? Guest: Dr. Joseph Palamar, Associate Professor in the Department of Population Health at NYU Langone who Specializes in Party Drugs Learn more about your ad choices. Visit megaphone.fm/adchoices
Can asparagus predict the future? Guest: Jemima Packington, The World's First and Only Asparamancer View From Victoria: What are the demands of the BC Greens? We get a local look at the top political stories with the help of Vancouver Sun columnist Vaughn Palmer Why isn't Parliament investigating Canada Soccer's drone scandal? Guest: Niki Ashton, MP for Churchill—Keewatinook Aski in Manitoba What is ‘pink cocaine'? Guest: Dr. Joseph Palamar, Associate Professor in the Department of Population Health at NYU Langone who Specializes in Party Drugs How did social media impact the provincial election? Guest: Aengus Bridgman, Director of the Media Ecosystem Observatory Is the Federal Liberal Party united or divided? Guest: Mackenzie Gray, Senior Correspondent for Global News National What are Indigo's best books of the year? Guest: Brandon Forsynth, Senior Category Manager of Print Experience at Indigo Learn more about your ad choices. Visit megaphone.fm/adchoices
Send us a textResources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55___________________________________________________________________The Provider Spotlight is a new bonus series of shorter episodes featuring doctors and specialists from past sessions—think of it as 'doctor shorts.' With over 25k scripts for Zepbound written weekly, many new subscribers haven't seen our earlier episodes, which helps them catch up quickly. Thanks for your support!On July 17th of 2023 Dr Alexandra set down with the Plus Sidez and discussed the affects of Metabolic Disorders & Mounjaro/GLP1 TreatmentsBIODr. Alexandra Sowa is the CEO and founder of SoWell Health, a consumer metabolic healthcare company. SoWell supports patients at every point of their health and weight loss journey through at-home laboratory testing kits, evidence-based nutraceuticals, and scalable telehealth access to medical weight management. Dr. Sowa is dual-board-certified physician of internal and obesity medicine and clinical instructor of medicine at NYU Langone. Dr. Sowa has served as a health expert for national media outlets and print publications like SiriusXM, CBS News, NPR, the New York Times, U.S. News, World Report, and more.You them find us at www.getsowell.com______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
SpaceX Crew Completes First Citizen SpacewalkBig news in the world of commercial space flight: On Thursday morning, Jared Iasaacman and Sarah Gillis, members of SpaceX's Polaris Dawn mission, became the first civilians to complete a spacewalk. The mission is a collaboration between Elon Musk's SpaceX and Isaacman, a billionaire tech entrepreneur. While outside the spacecraft, the two crew members conducted mobility tests on their spacesuits.SciFri Producer Kathleen Davis talks with Jason Dinh, climate editor at Atmos Magazine about this and other top science news of the week including deadly cholera outbreaks, germs at 10,000 ft, and Japanese eels that can escape a fish stomach through their gills.The First Successful Whole-Eye Transplant, Over A Year LaterIn May of 2023, there was a massive advance in the world of organ transplantation: the first whole human eye and partial face transplant. The man at the center of this procedure is 46-year-old Aaron James, who sustained significant facial injuries from a high-voltage work accident.At the time, it was unclear just how successful the operation would be. Previous tests in animals had resulted in shrinkage of the transplanted eye, if not outright rejection. But now, more than a year after the transplant, a new paper in the journal JAMA outlines the success of this first-of-its-kind operation. While James cannot see out of his new eye, there is blood flow, normal pressure, and a retinal response to light.Guest host Kathleen Davis speaks with Dr. Daniel Ceradini, director of research at NYU Langone's Department of Plastic Surgery and first author of the JAMA study. They discuss the implications this success could have for the future of eye surgery, and the dramatic improvements in James' quality of life.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
Academic medicine providers are increasingly depending on their clinical practices to fund their education and research divisions. How do academic medical providers balance financial performance with clinician and community needs amidst competing missions that challenge their business models? In this episode of Value-Based Care Insights, Daniel Marino sits down with Dr. Joseph Bosco, Professor and Vice Chair of NYU Langone's Health Orthopedics, and Jeff Peters, a national expert in growth and service line strategies, to explore how academic medicine is addressing conflicting missions across their enterprise. Gain insight into growth models in academic medicine that prioritize clinician and geographic accessibility to keep patients in-network, while maintaining a strong focus on research, education, and quality care.
Episode 109 Academic medicine providers are increasingly depending on their clinical practices to fund their education and research divisions. How do academic medical providers balance financial performance with clinician and community needs amidst competing missions that challenge their business models? On this episode Dan sits down with Dr. Joseph Bosco, Professor and Vice Chair of NYU Langone's Health Orthopedics, and Jeff Peters, a national expert in growth and service line strategies, to explore how academic medicine is addressing conflicting missions across their enterprise. Gain insight into growth models in academic medicine that prioritize clinician and geographic accessibility to keep patients in-network, while maintaining a strong focus on research, education, and quality care. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
The Park Fire, which is one of the largest in California's history, has destroyed over 60 structures. Meanwhile in southern California, crews are struggling to control the Borel Fire, which has burned close to 50,000 acres.Michigan Gov. Gretchen Whitmer, who serves as the co-chair of Vice President Kamala Harris' campaign, talks about the search for a vice presidential nominee and where the campaign stands, after President Biden dropped his bid for reelection.July marks Fibroid Awareness Month and Dr. Tara Shirazian from NYU Langone's Center for Fibroid Care joined "CBS Mornings" to discuss the condition and alternative treatments.After captivating the world with her drumming skills, Nandi Bushell releases her first book, "The Life Changing Magic of Drumming," and joins "CBS Mornings" to discuss her incredible journey.In her second Olympics, Ilona Maher is teaming up with brands to show young women they can be both strong and feminine, breaking barriers in the world of rugby.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Day in the Life of a Pediatric Urologist with Dr. Jordan Gitlin, MDIn this insightful episode, Dr. Jordan Gitlin, Chief Pediatric Urologist at NYU Langone, Long Island, shares his journey and inspiration behind choosing pediatric urology. Dr. Gitlin details his typical day, combining surgery, clinic visits, and teaching. He discusses the challenges of transitioning to robotic surgery, the nuances of treating pediatric patients, and the importance of being available for colleagues and patients. Dr. Gitlin also touches on his mission trips to Guatemala and the impact of maintaining relationships with his patients into adulthood. This episode offers a comprehensive look at the responsibilities and rewards of pediatric urology.00:00 Introduction and Guest Welcome01:06 Journey to Pediatric Urology03:51 A Day in the Life of a Pediatric Urologist08:21 Robotic Surgery in Pediatric Urology12:11 Challenges and Skills in Modern Surgery19:04 Handling Common Pediatric Urology Issues26:06 Reflux and UTI Management in Pediatrics33:47 Kidney Health and Reflux Management34:40 Challenges with DMSA Agent Availability36:05 Debate on Circumcision40:26 Managing Voiding Issues in Children44:01 Complex Pediatric Urology Cases47:14 Transitioning Special Needs Patients to Adult Care49:54 Mission Trips and Global Health54:24 The Importance of Physician-Patient Relationships56:22 The Role of Technology in Modern Healthcare01:00:33 Final Thoughts and FarewellSupport the Show.
Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of donanemab as a new treatment for adults with early symptomatic Alzheimer disease (AD). Marketed as Kisunla, donanemab's approval marks the third antiamyloid therapy to get FDA greenlight for early-stage AD, following the controversial approval of aducanumab (Aduhelm; Biogen) in 2021 and lecanemab (Leqembi; Eisai) in 2023. Donanemab, administered as a 350 mg/20 mL once-monthly injection for intravenous infusion, had its approval supported by the phase 3 TRAILBLAZER-ALZ-2 trial (NCT04437511), a large-scale, double-blind, placebo-controlled trial that featured 1736 patients with early-stage AD. Following the approval, NeurologyLive sat down with Joel Salinas, MD, MBA, a behavioral neurologist at NYU Langone and clinical assistant professor in the department of neurology at the NYU Grossman School of Medicine. Salinas, who also serves as the chief medical officer at Isaac Health, discussed the positive impacts of the approval, the importance of patient selection for the medication, and how clinicians should discuss its benefits and harms to patients. In addition, he commented on how approvals like donanemab continue to carry momentum in the AD field going forward. For more of NeurologyLive's coverage of donanemab's approval, head here: FDA Approves Eli Lilly's Donanemab for Early Symptomatic Alzheimer Disease Episode Breakdown: 2:10 – Positive downstream impacts of donanemab's approval 4:20 – Considerations and caution with prescribing donanemab 6:05 – Salinas on patient-clinician conversations about AD treatments 8:00 – Closing remarks and continued progress in AD field Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
Nicole Lund is a registered dietitian at NYU Langone's Sports Performance Center. A certified health and well-being coach and certified personal trainer, as a former dancer her love of movement led her into a career as a step aerobics instructor and personal trainer. Through her work, she recognized a need for a discussion about food and its impact on everything from performance to health. She sees medical nutrition therapy patients via insurance and self-pay sports. She is a clinician with the Running Lab and works with athletes on the USA Nordic team. Her expertise is in sports and performance nutrition while her clinical interests include chronic inflammation, weight loss, migraines, and menopause. She has a master's degree in public health nutrition from Hunter College. Part 2 The discussion covered the following topics: complementary and alternative therapies; accuracy of patients' nutrition knowledge; influence of demographic factors on the adequacy of nutritional status; provision of nutritional health care care via telehealth; prevention of health problems related to participating in vigorous physical activities; and how improved dietary practices may help to prevent health problems.
Nicole Lund is a registered dietitian at NYU Langone's Sports Performance Center. A certified health and well-being coach and certified personal trainer, as a former dancer her love of movement led her into a career as a step aerobics instructor and personal trainer. Through her work, she recognized a need for a discussion about food and its impact on everything from performance to health. She sees medical nutrition therapy patients via insurance and self-pay sports. She is a clinician with the Running Lab and works with athletes on the USA Nordic team. Her expertise is in sports and performance nutrition while her clinical interests include chronic inflammation, weight loss, migraines, and menopause. She has a master's degree in public health nutrition from Hunter College. Part 1 The discussion covered the following topics: how and when she began to develop an interest in performance nutrition; types of patients she treats; the role that diet plays in improving problems involving overweight and obesity; and use of dietary supplements by patients.
How great to connect with another Sarno OG! Karen, like me, sat across from Dr. Sarno in his iconic office at The Rusk Center for Rehabilitation at NYU/Langone in New York City back in the day when he was still in practice. His confident and unapologetic style was the inspiration for everything I do and teach, and Karen is right there with me. I have been hearing from Karen for years, as although Sarno was her intro to this work, she credits my contributions for taking her to the next level of wellness. Today we talk about her inspiring story, as well as dive into a bit of a Real Time Heal around her persistent symptoms of allergies and nasal congestion. Over the years (and in several interviews here on the pod) I've heard many people recount having terrible allergies only to connect them to TMS and have them resolve completely! It's such good stuff. Enjoy this powerful conversation! XO n. REMEMBER - QUALIFY TO WIN A FREE 1:1 SESSION WITH ME WHEN YOU SIGN UP FOR OMEGA BETWEEN NOW AND 5/1! COME TO OMEGA June 23-28th!!! Click here. Producer: Lisa Eisenpresser If you would like to be part of our Membership Community it's easy to do - just go to my website www.thecureforchronicpain.com and scroll down a bit. You'll see the button to join. PURCHASE LIVE FROM OMEGA (7 HOURS OF ORIGINAL TALKS!) PURCHASE MIGRAINE DEEP DIVE RECORDING! Sign up for my Membership Community on my Website (3 hour ZOOM with me once a month and separate monthly Q&A Hang with me alongside private online community where I answer your personal questions): https://www.thecureforchronicpain.com/ (Scroll down on home page to see the link.) Get 50% off the Curable App: www.getcurable.com/nicole Leave us a message on SpeakPipe! www.speakpipe.com/NicoleSachs New podcast music by the beautiful and talented Danielle Furst. Find her here: Insta - @musicfurst and all her amazing music credits here - https://www.imdb.com/name/nm3895994/ Past virtual retreats recordings available for sale now on my website: https://www.thecureforchronicpain.com/buy-retreat-recordings FREEDOM FROM CHRONIC PAIN course: https://www.thecureforchronicpain.com/course FREEDOM FROM AN ANXIOUS LIFE course: Click here for all the details and to purchase! PLEASE RATE AND REVIEW THE PODCAST HERE TO HELP OTHERS FIND IT! If you are interested in supporting the many free resources I offer to get this message to the global community, please consider donating to my cause on my website, www.thecureforchronicpain.com. Look for the DONATE button on the home page. Thank you so much! ALL MY RESOURCES: Instagram: Follow me on insta @nicolesachslcsw for tons of new content Website: The Cure for Chronic Pain YouTube: The Cure for Chronic Pain with Nicole Sachs, LCSW Book: The Meaning of Truth Online Course: FREEDOM FROM CHRONIC PAIN FB Closed Group:JournalSpeak with Nicole Sachs, LCSW OMEGA General info: OMEGA INSTITUTE Subscribe Apple Podcasts Deezer iHeart RadioPublic RSS Spotify
How great to connect with another Sarno OG! Karen, like me, sat across from Dr. Sarno in his iconic office at The Rusk Center for Rehabilitation at NYU/Langone in New York City back in the day when he was still in practice. His confident and unapologetic style was the inspiration for everything I do and teach, and Karen is right there with me. I have been hearing from Karen for years, as although Sarno was her intro to this work, she credits my contributions for taking her to the next level of wellness. Today we talk about her inspiring story, as well as dive into a bit of a Real Time Heal around her persistent symptoms of allergies and nasal congestion. Over the years (and in several interviews here on the pod) I've heard many people recount having terrible allergies only to connect them to TMS and have them resolve completely! It's such good stuff. Enjoy this powerful conversation! XO n. REMEMBER - QUALIFY TO WIN A FREE 1:1 SESSION WITH ME WHEN YOU SIGN UP FOR OMEGA BETWEEN NOW AND 5/1! COME TO OMEGA June 23-28th!!! Click here. Producer: Lisa Eisenpresser If you would like to be part of our Membership Community it's easy to do - just go to my website www.thecureforchronicpain.com and scroll down a bit. You'll see the button to join. PURCHASE LIVE FROM OMEGA (7 HOURS OF ORIGINAL TALKS!) PURCHASE MIGRAINE DEEP DIVE RECORDING! Sign up for my Membership Community on my Website (3 hour ZOOM with me once a month and separate monthly Q&A Hang with me alongside private online community where I answer your personal questions): https://www.thecureforchronicpain.com/ (Scroll down on home page to see the link.) Get 50% off the Curable App: www.getcurable.com/nicole Leave us a message on SpeakPipe! www.speakpipe.com/NicoleSachs New podcast music by the beautiful and talented Danielle Furst. Find her here: Insta - @musicfurst and all her amazing music credits here - https://www.imdb.com/name/nm3895994/ Past virtual retreats recordings available for sale now on my website: https://www.thecureforchronicpain.com/buy-retreat-recordings FREEDOM FROM CHRONIC PAIN course: https://www.thecureforchronicpain.com/course FREEDOM FROM AN ANXIOUS LIFE course: Click here for all the details and to purchase! PLEASE RATE AND REVIEW THE PODCAST HERE TO HELP OTHERS FIND IT! If you are interested in supporting the many free resources I offer to get this message to the global community, please consider donating to my cause on my website, www.thecureforchronicpain.com. Look for the DONATE button on the home page. Thank you so much! ALL MY RESOURCES: Instagram: Follow me on insta @nicolesachslcsw for tons of new content Website: The Cure for Chronic Pain YouTube: The Cure for Chronic Pain with Nicole Sachs, LCSW Book: The Meaning of Truth Online Course: FREEDOM FROM CHRONIC PAIN FB Closed Group:JournalSpeak with Nicole Sachs, LCSW OMEGA General info: OMEGA INSTITUTE Subscribe Apple Podcasts Deezer iHeart RadioPublic RSS Spotify
Today on the Balancing Chaos Podcast, Kelley sits down with renowned dermatologist and clinical associate professor at NYU Langone, Dr. Doris Day. Her dedication to patient care, lifelong learning, and advancing dermatological techniques has earned her accolades and widespread recognition. Dr. Day is the author of three books, Beyond Beauty: Using the Power of Your Mind and Aesthetic Breakthroughs to Look Naturally Young and Radiant, Forget the Facelift: Turn Back the Clock with Dr Day's Revolutionary Four-Step Program for Ageless Skin, and 100 Questions and Answers about Acne.Through this episode, Kelley and Dr. Day cover a variety of different topics around what is impacting the aging process from the reality of how bad the sun really is for skin to how hormones impact the aging process and how bioidentical hormone replacement therapy can be helpful in maintaining youthful glowing skin. Additionally, through the interview they discuss the real risks of Botox, how weight loss drugs create more fine lines and wrinkles and the right age to get a facelift! Tune in for an insightful episode to get tangible tips on how to get radiant glowing youthful skin that defies time! To connect with Kelley Nemiro click HERETo book Kelley's Lab Review Package click HERETo connect with Dr. Doris Day click HERE
Former President Trump has won the New Hampshire primary, beating his last GOP opponent former UN Ambassador Nikki Haley in a closer than expected race. Political pundits and primary polls alike forecast that Trump will handily win the next primary in Haley's home state of South Carolina, which could cement his status as the GOP's nominee for president in 2024. Meantime, President Biden won his primary bid against Minnesota Congressman Dean Phillips, led by a write-in campaign following the DNC's decision to move the first primary of their election calendar to South Carolina. Fox News Radio political analyst Josh Kraushaar and Fox News Audio Political Anchor and Washington Correspondent Jared Halpern join the Rundown to discuss Nikki Haley's decision to speak first following the primary being called for the former President, what the win means for the Trump campaign, and what Haley will do to make up ground going into the South Carolina primary. More than six million American seniors are diagnosed with Alzheimer's disease, and experts say the number will double in the next 25 years. However, a new study released this week shows there may be hope for early detection. Researchers in Sweden discovered that specific proteins found in blood can accurately detect the disease before symptoms arise. FOX News medical correspondent and Professor of Medicine at NYU Langone, Dr. Marc Siegel, joins the Rundown to discuss how Alzheimer's affects the body, share how the new test works, and explain why younger patients may want to take preventative measures. Plus commentary from host of the Jason Rantz Show on KTTH 770AM/94.5 FM Jason Rantz. (Image: Pablo Martinez Monsivais Via AP) Learn more about your ad choices. Visit megaphone.fm/adchoices
Dr. Sue Varma began her career as the first medical director and attending psychiatrist to the World Trade Center Mental Health Program at NYU Langone, helping survivors overcome trauma and PTSD. She then began using her methods to help people overcome the negative mindset, feelings, and emotions that come from trauma and loss. In this episode, she gives us her top three things to beat pessimism. Learn how to shed a victim mentality, boost oxytocin, manage anger and agitation effectively, and so much more!Guest Links:Website: https://www.doctorsuevarma.com/IG: @doctorsuevarmaSuicide & Crisis Lifeline: 988 For 25% off The Fitness App by Jillian Michaels, go to www.thefitnessapp.com/podcastdealFollow us on Instagram @JillianMichaels and @MartiniCindyJillian Michaels Community: https://www.facebook.com/groups/1880466198675549Email your questions to JillianPodcast@gmail.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The holiday shopping season has officially begun with an estimated 130 million people planning to “shop 'til they drop” this Black Friday. But the deals are no longer restricted to Friday, with many retailers rolling out holiday discounts earlier this month. This change is causing some to question whether or not Black Friday is still the best day for discounts. Founder and CEO of Storch Advisors, Gerald Storch, joins the Rundown to explain why he thinks Black Friday is more of a "concept" and not a holiday, why consumers are spending more right now, and share why he believes it will be a slow holiday season for retailers. Nearly forty percent of adults in the United States are considered obese, and many people are looking for a quick and easy way to lose weight. Ozempic, a popular drug used to treat diabetes, skyrocketed in popularity after celebrities began using it for weight loss. Now, doctors fear the long-term effects the drug may have on the world of health and fitness. FOX News Medical contributor and NYU Langone professor Dr. Marc Siegel explains how these drugs work, how overprescription of these drugs will hurt diabetes patients who need them, and how Ozempic became such a sought-after drug. Don't miss the good news with Tonya J. Powers. Plus, commentary by a former investment banker and author of 'You Will Own Nothing,' Carol Roth. Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2025 Ivy Podcast Discovery LLC
